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. Characteristics of the patients from 0 (bad) to 100 (excellent) [9, 10] .
The uraemic symptoms profile [11] , consisting of several renal failure or dialysis related symptoms, scored from 0 n 13 (bad) to 4 (absent or excellent).
Age (year) 50.0±11.9 Gender male 10, female 3
Also, all patients completed a 7-day nutritional diary.
Months on dialysis 116±81. 2 Then patients started a 6 times a week dialysis schedule
Renal disease ('daily dialysis') over 6 months. During these months, the glomerulonephritis without systemic 3 artificial kidney, blood flow, and dialysate did not change. disease The dialysis duration was adjusted so that weekly Kt/V was glomerulonephritis with systemic 3
similar to values found in the run-in period. Every 8 weeks, disease several measurements were done as described in complete an evaluation questionnaire. They were asked whether uraemic symptoms existed and whether these symptoms, if present, improved, worsened, or remained constant. 
Results
the dose of i.v. iron had to be increased in these patients, resulting in higher serum ferritin concentraUrea kinetics tions in week 24. See Table 3 . Urea kinetics revealed that weekly Kt/V indeed could be kept constant, as was determined by Haemodynamic control the protocol, nPCR remained constant also, while TACu decreased sharply in the first 8 weeks, and Systolic blood pressure and mean arterial pressure increased thereafter. The urea reduction per dialysis (MAP), measured over 24 h, decreased significantly session decreased significantly, due to shorter dialysis (P<0.001 and P<0.02 respectively). Diastolic blood treatment.
pressure decreased as well, but this change did not reach significance ( Table 4 ). The decrease of blood pressure was apparent after only 8 weeks.
Metabolic control
Patients in whom baseline MAP was higher than the In Table 3 we show the results of determinations at median value (100 mmHg, n=7) showed a significant baseline, week 8 and week 24, since there were no decrease of blood pressure (P<0.05). When baseline significant differences detectable between weeks 8 and MAP was lower than the median value the MAP 16. Pre-and post-dialysis serum potassium concentra-decreased as well, but this change did not reach tions did not change. However, the amount of potas-significance (see Table 4 ). sium binding resins that were taken by four patients
In eight patients using antihypertensive drugs, could be decreased (from 10.6±2.6 g/day to 1.2± the number of antihypertensives could be reduced 1.3 g/day, P<0.02). from 1.88±0.35 to 0.75±0.17 (P<0.0005). Clinically Serum bicarbonate concentrations were normal and assessed dry weight increased from 71.0±17.6 kg did not change throughout the study. Serum phos-to 71.8±17.3 kg. Weekly cumulative ultrafiltration phate, already being satisfactorily regulated, decreased. volume increased with more than a litre per week, but Serum calcium remained constant. The amount of this increase did not reach statistical significance. aluminium-containing phosphate-binding agents de-Ultrafiltration volume per session decreased significcreased slightly from 2.5±0.9 g/day to 1.9±0.6 g/day, antly (P<0.00001). These lower fluctuations resulted while the dose of calcium-containing agents remained in a marked improvement of dialysis stability and the constant (2.9±0.5 g/day and 2.8±0.6 g/day). Serum total disappearance of muscular cramps during and iPTH and alkaline phosphatase did not change.
after dialysis. Total protein content of the serum and serum albumin concentrations did not change significantly. Serum Quality of life cholesterol increased significantly, while HDL-cholesterol and triglyceride concentrations remained con-The Nottingham Health Profile showed a significant improvement of energy (P<0.05). Patients reported stant. Haematocrit and erythropoietin dose remained constant throughout the study. However, serum ferritin less pain, a better emotional reactivity, less insomnia, and a better mobility, but these changes did not reach ies directly after dialysis. All patients judged the more statistical significance. Social isolation tended to frequent dialysis schedule as an improvement, and worsen, but this change was not significant either (see continued a six times per week or five times per Table 5 ). week dialysis schedule after the end of the study (see The RAND 36 showed a statistically significant Table 7 ). improvement of physical functioning and mental health (P<0.02 and P<0.05 respectively). Limitations due to physical and emotional role limitations, mental health, Vascular access vitality, pain, and a positive perception of change of During the run-in and study periods, no thrombosis health and perception of health improved, but these or bleeding occurred. There was no indication that improvements were not statistically significant. Social frequent use of the vascular access results in a higher functioning worsened, which was also not significant (see Table 5 ).
incidence of these complications. The uraemic symptoms profile showed a significant improvement of fatigue (P<0.02) and thirst (P<0.03). Several other symptoms (prurigo, insomnia, dyspnoea, Costs anorexia) improved as well, but these changes did When the costs of DHHD are compared to other not reach significance. No symptoms worsened (see dialysis techniques, one can roughly state that the costs Table 6 ).
of DHHD with assistance of a nurse is comparable to The results of the evaluation questionnaire are sumin-hospital thrice-weekly haemodialysis, and the costs marized in Table 6 . Dialysis-induced adverse symptoms of DHHD without a nurse are comparable to the costs (e.g. headache, nausea, fatigue) disappeared in all patients; patients were fit for their normal daily activit-of CAPD (see Figure 1 ). 
Case histories
To illustrate the impact of daily dialysis on clinical outcome in the individual patient, we describe the cases of three patients. Patient A is a male, 69 years of age, suffering from end-stage renal disease because of Wegener's disease. He was treated with in-centre haemodialysis for 2 years without major complications. In 1995 he developed angina pectoris and consulted a cardiologist. Despite pharmacological treatment, he developed a large inferior myocardial infarction, with considerable damage to the myocardium, and leading to forward failure of the heart. During 4 months, haemodialysis was unstable because of hypotension despite overhyd- Fig. 1 . Comparison of total yearly costs of several dialysis modalities ration, and frequent additional dialysis sessions were in The Netherlands, including all costs of supplies, infrastructural necessary because of lung oedema. We considered organization, staff, hospitalization, laboratory investigation, other his life expectancy to be very low. His body weight diagnostic procedures, medication, further medical consumption, decreased by more than 4 kg. Then we started six and travel costs. 1Hfl is approximately 0.5 $US. CuD-a, conventional times per week in-centre dialysis, and later DHHD.
self care 'active' in-centre haemodialysis; CHD-p, conventional 'passive' in-centre haemodialysis; HHD-p, conventional home Dialysis became stable, symptoms of over-and dehydhaemodialysis with assistance of a partner; HHD-n, conventional ration disappeared, his clinical condition improved, home dialysis with assistance of a nurse; DHHD-p, daily home the incidence of angina pectoris decreased markedly, haemodialysis with partner; DHHD-n, daily home haemodialysis and his body weight could be increased by 2.5 kg in with assistance of a nurse; CAPD, continuous ambulant peritoneal dialysis; APD, automated peritoneal dialysis.
months.
Patient B is a 58-year-old male with nephrosclerosis, treatment to take urea rebound effects into account.
The results were therefore lower than if sampling had being treated with dialysis for 10 years. He had an uncontrollable hypertension. Despite strict ultrafiltra-been performed according to the recent NKF-DOQI guidelines on dialysis adequacy [13] , and consequently tion policy and three antihypertensive drugs (enalaprilat, atenolol, and amlodipine), he was still hypertensive they cannot be compared with the values as recommended by these guidelines. (170/95 mmHg at the end of dialysis). Four months after the start of DHHD, his blood pressure was
Other papers on daily dialysis show increased values for Kt/V. Indeed, it is easy to increase dialysis dose in 110/75 mmHg after dialysis. At that time, he only used enalaprilat 2.5 mg daily and his target weight had been a more frequent schedule, since a small daily increase of dialysis duration results in a significant increase of increased by 0.5 kg. Six months after start of DHHD, his blood pressure was 115/70 mmHg at the end of weekly dialysis dose. Currently, more than 6 months after discontinuation of our study, all 13 patients dialysis without any antihypertensive drugs and a target that was 2.5 kg above baseline. A few weeks studied show a weekly Kt/V between 4.0-6.0.
Urea reduction per session decreased significantly, later, he had to stop DHHD because of logistical problems, and within 4 weeks his blood pressure was which may be partly responsible for the better tolerance of the treatment. TACu decreased in the first 8 weeks 170/100 mmHg at the same target weight, and with antihypertensive drugs including enalaprilat 5 mg daily after starting DHHD, but increased thereafter. An increasing TACu combined with a constant Kt/V sugand amlodipine 10 mg daily. Soon after restarting DHHD, his blood pressure normalized again.
gests an improved protein intake, provided that the patient is not catabolic, which is, in our studied group, Patient C is a 27-year-old male without a known cause for his renal insufficiency. He had been on unlikely since target weight increased. However, nPCR, being adequate, remained constant and we could not dialysis for 4 years. He had many adverse symptoms during conventional dialysis, including cramps, hang-show a higher protein intake using the nutritional diaries nor an increase of serum albumin concentration over, and fatigue. He was non-compliant with respect to fluid restriction. Several days of the week, he was (which was also adequate). The elevation of target weight form 71.0±18.3 kg at baseline to 71.2±18.2 in unfit to work and felt tired and sick. Being an information technology specialist, he cold not find a suitable week 8 and 71.8±18.0 in week 24 suggested an anabolic state; however, this increase was not significant part-time job in this demanding field, resulting in frustration, depression, and even psychotic symptoms. (P=0.19). In conclusion, we could not show an improved nutritional status in these stable patients He started DHHD; his health perception increased within a few weeks, and the dialysis-related symptoms who did not show objective signs of malnourishment before DHHD commenced. disappeared completely. He found a very demanding full-time job as IT specialist and is able to perform well.
As mentioned before, the metabolic changes are less pronounced than reported by other groups [2] [3] [4] [5] [6] . There may be several reasons for this. Firstly, unlike Discussion the previous reports, we did not increase total dialysis dose, and the reported effects are solely due to an increased frequency. The discrepancy between our The present study was carried out to investigate the effects of increasing dialysis frequency (from three results and the previously published data with respect to metabolic changes may signify that at least part of times per week to six times per week without changing weekly dialysis dose), on metabolic control, haemo-the amelioration shown in the previous studies was due to an increased dialysis dose, and not merely to dynamic control, and quality of life. In summary, we observed better volume and blood pressure control, an increased frequency. Secondly, the baseline metabolic situation was optimized in all patients before more stable dialysis sessions, a slightly improved phosphate control, a decrease of several uraemic or dialysis they started the DHHD programme (this was a requirement in the protocol ). Thirdly, medication (e.g. dose induced symptoms, and a better physical and mental health.
of phosphate binding agents and potassium-binding resins, erythropoietin, iron) was adjusted during These results confirm the improvements of haemodynamic control and quality of life that have been the study. Metabolic changes may have been more pronounced when medication had been kept constant. shown by previously published studies [2] [3] [4] [5] [6] , but the metabolic changes were less striking in our study. In
As to phosphate, the nutritional diaries showed a small increase of phosphate intake, and the dose of these previous studies, not only dialysis frequency, but also weekly dialysis dose had been altered. Until now, phosphate binding agents was decreased slightly. These factors may have accounted for a less prominent drop there are no clinical data on the effects of an increased dialysis frequency without an increased dialysis dose of serum phosphate concentration. However, as phosphate removal is high in the first hour of dialysis and on clinical outcome.
Dialysis dose was measured by Kt/V, and weekly then rapidly declines [14] , we had expected larger effects of DHHD on phosphate control. Kt/V was kept constant throughout the study (3.2 per week). For the interpretation of these results, it is As to erythropoiesis, the fact that rHuEpo dose could not be decreased may have been due to decreasnecessary to recall that post-dialysis urea samples were taken 15 min after discontinuation of the dialysis ing serum ferritin concentrations, possibly as a result of increased iron losses More iron supplementation is related to the dialysis treatment itself were not taken into account in the calculation of the additional costs necessary in DHHD patients than in those treated with conventional schedules.
of DHHD. When frequent dialysis indeed results in lower drug use and less morbidity and hospitalization, The rise of serum cholesterol cannot be ascribed to to more frequent heparinization, since anticoagula-the overall cost-effectiveness of the treatment may be better when compared to conventional dialysis treattion took place with low-molecular-weight heparin (Nadroparin), which is not associated with higher ments. However, the number of patients in this study is too small and the study period too short to verify serum cholesterol concentrations. Serum triglycerides and HDL cholesterol concentrations remained such speculations.
Daily in-centre dialysis will of course be much more constant.
Haemodynamic changes were more pronounced. expensive and troublesome for patients. One can speculate that improved haemodynamic control and more Blood pressure normalized in the hypertensive patients, and antihypertensive medication had to be consider-stable dialysis may justify the referral of older, typical in-hospital, dialysis patients with cardiovascular disably reduced to prevent hypotension. Target weight increased. The mechanism for a better blood pressure ease and perhaps unstable dialysis sessions to more frequent dialysis, and later to daily home haemodiacontrol is not known. More frequent ultrafiltration of lower volumes resulted in more stable dialysis sessions, lysis, which will result in a higher quality of the treatment for the same costs (see case history A). which may have been important to achieve an accurate dry weight. On the other hand one may speculate that Which patients will benefit from daily dialysis? In our opinion, DHHD will improve the clinical situation smaller amplitudes and lower peaks of body fluid volume have as yet unknown effects on the activation markedly in the following categories of patients: those with heart failure, patients with uncontrollable hyperof vasoconstrictive factors or sympathetic activation. In our opinion, this hypothesis certainly needs further tension, patients with severe non-compliance with respect to fluid intake, patients who cannot endure investigation. The lower fluctuations of body fluid volume were correlated with the disappearance of long dialysis sessions, and patients with severe dialysisinduced symptoms. dialysis-induced hypotensive periods and muscle cramps. These effects can be of importance in hyper-
In conclusion, doubling haemodialysis frequency without changing dialysis dose is beneficial. The posittensive patients and patients with heart failure, as case histories A and B show.
ive effects after 6 months on haemodynamic control and quality of life are more pronounced than on Quality of life improved markedly. All patients considered the advantages of DHHD far more import-metabolic control. The costs of DHHD are comparable to other renal replacement treatments. ant than the disadvantages, and continued a frequent schedule after discontinuation of the study. The major
